Clinical Trial Seeking Adults with Eczema

BEACON Trial comparing eczema treatments

 A UK wide study is recruiting people over 18 who have moderate/severe eczema. They are looking at the effectiveness of FOUR treatments - ciclosporin, methotrexate, dupilumab or abrocitinib.

Mild eczema can usually be treated with creams and ointments, but more severe eczema needs systemic treatments (medicine taken by mouth or injection). Ciclosporin is the only licensed standard treatment and methotrexate is the most commonly prescribed standard treatment in the UK.

New systemic treatments have recently been developed for eczema. Dupilumab became available on the NHS in 2019, but so far it has not been compared with the standard systemic treatments already available and commonly used.

Can you help the BEACON team research new advanced therapies for eczema? If you have eczema, or you are clinician treating patients with eczema, find out how to get involved on their website, link below, and select 'Take Part' or email the study team: beacon@kcl.ac.uk 

BEACON Trial website